FDA Takes Steps to Curb Orphan Drugs

opioid lawsuits

FDA Commissioner Scott Gottlieb announced that he is taking steps to deal with abuses in the development of sorphan drugs by closing lucrative loopholes open to pharmaceutical companies. The Orphan Drug Act of 1983 provides incentives to research and produce drugs used to treat rare conditions. Incentives to produce drugs that be otherwise financially infeasible…

Read More